Medtech company Enovis has tapped Damien McDonald as its new CEO, taking over the role on May 21.
Mr. McDonald will succeed Matt Trerotola, who recently announced plans to retire, according to an April 2 company news release.
Mr. McDonald has more than 35 years of experience in the medical device industry, most recently serving as CEO of LivaNova.
Enovis projects first-quarter revenue between $555 million and $563 million and an adjusted EBITDA in the range of $97 million to $100 million.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
